Take Control of Your Leukemia Treatment Journey
Living with leukemia can feel overwhelming, but having clear, accurate information about your treatment response brings peace of mind and empowers you to make informed health decisions. The BCR-ABL1 Quantification test is your partner in monitoring treatment effectiveness, giving you and your healthcare team the precise data needed to ensure your therapy is working optimally.
Understanding Your BCR-ABL1 Test
The BCR-ABL1 Quantification by Droplet Digital PCR is a sophisticated blood test that measures the amount of BCR-ABL1 fusion gene in your blood. This specific genetic abnormality is characteristic of certain types of leukemia, particularly chronic myeloid leukemia (CML). By tracking these levels over time, your doctor can determine how well your treatment is controlling the disease.
Using advanced droplet digital PCR technology, this test provides exceptionally accurate measurements, detecting even minute changes in gene levels that might indicate treatment resistance or disease progression.
Who Should Consider This Test?
This test is essential for:
- Patients diagnosed with chronic myeloid leukemia (CML) undergoing tyrosine kinase inhibitor therapy
- Individuals with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
- Patients experiencing changes in blood counts during treatment
- Anyone whose doctor needs to monitor treatment response and potential resistance
- Patients wanting precise, quantitative data about their disease status
If you’re currently on leukemia treatment and want to ensure your therapy remains effective, this test provides the clarity you need.
Why This Test Matters for Your Health
Regular BCR-ABL1 monitoring offers significant health advantages:
- Early Detection of Treatment Resistance: Identify potential issues before they become serious problems
- Treatment Optimization: Help your doctor adjust medications for better outcomes
- Peace of Mind: Know exactly how your body is responding to therapy
- Proactive Health Management: Stay ahead of your treatment journey with regular monitoring
- Improved Quality of Life: Better disease control means fewer complications and hospital visits
Understanding Your Test Results
Your results will show the percentage of BCR-ABL1 transcripts relative to a control gene. Don’t worry about interpreting these numbers alone – your doctor will explain what they mean for your specific situation. Generally:
- Decreasing Levels: Indicates your treatment is working effectively
- Stable Low Levels: Suggests good disease control
- Increasing Levels: May indicate treatment resistance or disease progression
Remember, these results are just one piece of your overall health picture. Your doctor will consider them alongside your symptoms, physical examination, and other test results.
Affordable, Life-Changing Monitoring
| Test Option | Price | Turnaround Time |
|---|---|---|
| BCR-ABL1 Quantification by DD PCR | ZAR 3,000 (Regular ZAR 4,000) | 2-3 Days |
Consider this an investment in your health – early detection of treatment issues can prevent costly complications and hospitalizations down the line.
Why Trust Oracle Genomics?
We understand that cancer monitoring requires absolute accuracy and reliability. That’s why we use:
- Advanced Droplet Digital PCR Technology: For unparalleled precision in measurement
- Nationwide Coverage: Accessible testing in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Expert Medical Team: Specialists who understand oncology testing requirements
- Rapid Turnaround: Results within 2-3 days to support timely treatment decisions
- Quality Assurance: Stringent quality controls ensuring reliable results every time
Take the Next Step in Your Health Journey
Don’t wait to get the clarity you deserve about your treatment effectiveness. With our special ZAR 3,000 pricing, there’s never been a better time to take control of your leukemia monitoring.
Note: This test requires a doctor’s prescription for accurate interpretation and follow-up care. Our team can help coordinate with your healthcare provider if needed.
Early detection of treatment resistance can make all the difference in your leukemia journey. Book your BCR-ABL1 test today and gain the peace of mind that comes with knowing exactly how your treatment is working.
